Glutathione Protocol: How to Cycle It, Timing & What to Expect

Protocol snapshot

• Typical cycle length: 8 to 12 weeks active, followed by a 2 to 4 week off-cycle break; skin brightening protocols often run 10 to 12 weeks before transitioning to maintenance
• Frequency: 2 to 3 times per week for injectable routes; daily for oral forms; maintenance phase drops to bi-weekly or monthly
• Common delivery routes: Subcutaneous injection, intramuscular injection, intravenous infusion, oral (including liposomal formulations)
• Key timing notes: Consistency across fixed injection days matters more than exact time of day; the roughly 72-hour half-life means irregular dosing creates gaps in sustained levels

Who This Protocol Is For

A glutathione protocol attracts users across three primary goals: general antioxidant and cellular protection, liver and immune detoxification, and skin brightening. Each draws on the same compound, but the delivery route, frequency, and phase structure differ depending on which goal is driving the cycle.

The general wellness crowd tends toward lower-frequency injectable or oral protocols, looking for protection against oxidative stress, support for healthy aging, and a lift in recovery and energy. People running detox-focused protocols often have a specific window in mind, such as a high-stress stretch or a heavy training block, and typically use injectable routes at a moderate frequency. Skin brightening is a distinct goal with its own protocol shape: higher frequency during the loading period, a longer active phase, and close attention to interval consistency.

Experience level matters here more than with some compounds. Someone new to injectables typically starts at the lower end of the initiation phase to confirm tolerability and build familiarity with administration. More experienced users may move through initiation faster or enter the active phase higher within the range.

Delivery-route preference is also a genuine fork in the road. Subcutaneous and intramuscular injections are the most common approaches for self-administered protocols. IV infusions are used primarily in supervised clinical settings where faster onset and higher bioavailability justify the cost and access. Oral glutathione, including liposomal formats, is a lower-barrier option, though bioavailability is substantially lower and real-world user reports on efficacy are more variable.

How Is a Glutathione Cycle Structured?

A glutathione cycle moves through three phases: an initiation phase, an active phase, and a maintenance phase, followed by an off-cycle break. The full arc typically covers 8 to 12 weeks of active use, with skin brightening protocols often running closer to the longer end. The full mechanics of each phase are covered in the Loading and Maintenance Phases section below.

Glutathione is not FDA-approved for antioxidant use, detoxification, or skin lightening, and no universal clinical standard governs these protocols. Tested athletes should verify current WADA status before starting.

How Your Dose Is Determined

What moves a glutathione dose:

• Your goal: This is the single biggest lever. General antioxidant and cellular support protocols sit toward the lower end of the range at a modest frequency. Immune and detox protocols trend toward the middle, using a moderate injection cadence. Skin brightening protocols, particularly intensive clinical variants, trend toward the higher end of the frequency band and the upper portion of the dose range, because the melanin pathway response is dose-dependent and builds more slowly than energy or antioxidant effects.
• Experience level: Someone new to glutathione injections typically lands in the lower portion of the range during initiation and moves up deliberately. More experienced users who know their tolerance and response may enter the active phase higher within the range.
• Delivery route: The route determines both the dose and the bioavailability of what is actually delivered. IV infusions offer the highest bioavailability, so the dose per session tends to be larger but more efficiently absorbed. Subcutaneous and intramuscular injections offer intermediate bioavailability. Oral glutathione requires a higher raw input to offset substantially lower bioavailability through the digestive tract. These routes are not interchangeable on a one-to-one basis; moving between them means recalibrating the dose, not just the delivery method.
• Individual response: Two people with identical goals and routes can land in different places because baseline glutathione levels, oxidative stress burden, and the underlying reasons for supplementing all vary. Someone with significantly depleted baseline levels may respond more noticeably at a lower dose; someone in generally good oxidative health may need a higher input to see the same effect.

No single number fits everyone, and the goal, route, and starting point together shape what an appropriate protocol looks like. That variability is exactly why the personalized dose belongs in the app.

Your dose should not be a guess. The MyPeptidePal Protocol Creator takes your specific goal (antioxidant support, detox, or skin brightening), your preferred delivery route, and your experience level with injectables and builds your glutathione protocol: your dose, your cycle, and your timing.

Get your protocol at mypeptidepal.ai

How Often Do You Take Glutathione?

Injectable glutathione is most commonly run two to three times per week during the active phase. That frequency is grounded in the compound's approximately 72-hour half-life: glutathione stays active in the system for roughly three days before levels begin to drop meaningfully. Spacing injections across the week keeps levels from bottoming out between doses and maintains therapeutic momentum. Dropping below that cadence, particularly to once per week, means tolerating a longer gap where circulating levels decline before the next dose restores them.

For skin-focused goals where finer-grained level management is a priority, some protocols split the weekly dose into two smaller injections on the same day rather than once per session, though once or twice per week remains the more common pattern for most injectable users.

During the maintenance phase, once the primary goal has been substantially met, frequency drops to bi-weekly or monthly. The objective shifts from building levels to sustaining what has been achieved.

Oral glutathione follows a different pattern. Because bioavailability through the digestive tract is substantially lower, oral protocols are typically dosed daily to compensate.

Within the day, timing is less critical than the interval between doses. Morning dosing aligns with liver metabolic activity and suits detox-focused users; evening dosing provides antioxidant coverage for oxidative stress accumulated across the day and is often preferred for skin or recovery goals. Either approach works as long as injection days stay consistent from week to week. Injection sites should be rotated systematically across the abdomen, thigh, and upper arm to reduce tissue irritation.

Loading and Maintenance Phases

The initiation phase runs through the first one to two weeks. Its purpose is not to deliver a dramatically higher dose, but to establish consistent use, assess tolerability, and confirm there are no adverse reactions before settling into the full active protocol. The dose during initiation sits toward the lower end of the active range, at the same frequency the active phase will sustain. A key structural point: there is no separate elevated loading dose above the active phase dose. The initiation phase runs lower within the same range, then the active phase sustains the target. The dose stays consistent across both phases.

From week three onward, the protocol moves into the active phase at the primary dose and frequency for the goal in question. This is sustained through weeks 8 to 12 depending on the target. Skin brightening protocols typically extend closer to 10 to 12 weeks because the melanin pathway effects build gradually and continue developing across a longer active phase. Antioxidant and detox goals often see meaningful change in the earlier part of that window.

Toward the end of the active phase, most protocols taper into maintenance: dropping frequency to bi-weekly or monthly while holding the goal-level dose. This is the same protocol at lower frequency, sustaining benefits rather than continuing to build them. If a protocol uses IV in a supervised clinical setting, the dose per session may be substantially higher and the frequency lower than a self-administered injectable protocol, but the same initiation-to-active-to-maintenance logic applies.

Off-Cycle Considerations

Off-cycle breaks serve a specific purpose rooted in how the compound works. When exogenous glutathione is supplemented consistently over weeks, there is a concern that the body may reduce its own endogenous glutathione synthesis in response. Taking a break allows natural production to reassert itself, which matters for long-term antioxidant function independent of supplementation.

The most common pattern is two to four weeks off after every 8 to 12 weeks of active use. Some protocols follow a longer structure of roughly 10 weeks on before the break; others cycle shorter, with four to eight weeks on and a two to four week break. The goal in each case is the same: prevent the body from becoming reliant on exogenous supply and give endogenous production room to recover.

During the off-cycle period, some users support glutathione levels indirectly through N-acetyl cysteine, commonly called NAC. It provides cysteine, the rate-limiting amino acid in the body's own glutathione synthesis, and is the most commonly cited supporting supplement for the break period. This is not a substitute for the full protocol but can help sustain some antioxidant baseline.

For people using glutathione primarily for skin brightening, the off-cycle often means transitioning to a low-frequency maintenance schedule rather than stopping entirely, since skin effects fade gradually when the compound is withdrawn. Monthly or bi-monthly injections are common in this context.

What to Expect Week by Week

• Week 1 to 2: Effects during the initiation phase are typically subtle. IV users sometimes report an energy increase within the first few days. For subcutaneous and intramuscular users, week one and two are mostly about tolerability: the body adjusting, injection site response settling, and the routine establishing itself. Visible skin changes, if any, are minimal at this stage.
• Week 3 to 4: The active phase starts showing early returns. Reduced muscle soreness after training is commonly reported by week two to three for injectable users. A mild but noticeable skin brightness or improved glow appears for some users in this window. Energy and recovery improvements tend to be more consistent by week three than during initiation.
• Week 5 to 8: This is where the most widely reported changes accumulate for both antioxidant and skin goals. Tangible skin brightening, fading of uneven tone and blemishes, and improved skin uniformity are commonly reported from week four or five onward. Dark circle reduction becomes more noticeable in weeks six to eight. Antioxidant and detox users often report a stable, improved baseline in energy and recovery tolerance across this window. Oral users typically notice effects later in this range, if at all, given lower bioavailability.
• Beyond 8 weeks: For skin brightening specifically, users commonly report reaching peak effects in the week 8 to 12 range. Many users report noticeable skin tone improvement and reduced hyperpigmentation by cycle end.

These are commonly reported ranges drawn from user protocols and real-world use, not guaranteed outcomes. Individual results vary based on delivery route, consistency of dosing, baseline glutathione status, and the goal being pursued. A well-structured cycle, run consistently at the right frequency with proper site rotation and storage, commonly produces a clear arc: subtle early changes in weeks one to two, building effects through the mid-cycle, and peak antioxidant and skin results in the final weeks for users who stay the course.

Common Protocol Mistakes

Skipping or shortening the initiation phase. Jumping to the full active protocol from day one is common among motivated users with skin brightening goals. The initiation phase exists to check tolerability and let the system adjust. A poorly tolerated reaction in week one is harder to manage when you are already at the upper end of the range.

Inconsistent injection intervals. Given the roughly 72-hour half-life, irregular dosing lets levels drop back down between doses before the next injection restores them. Skipping an injection and doubling up on the next one does not compensate; it disrupts the sustained level that the schedule is designed to maintain. The fix is a consistent schedule on fixed days each week.

Poor reconstitution practice. Glutathione dissolves reliably only within a specific concentration range. Using the wrong water volume throws off the final concentration, which affects dosing accuracy and can leave particulate matter in the solution. If reconstitution is part of your protocol, follow your compounding pharmacy or provider's specific instructions for water volume and handling, and verify the solution looks correct before use.

Ignoring reconstituted shelf life. Reconstituted glutathione has a limited refrigerated shelf life, and using it beyond that window risks both potency loss and contamination. Follow your pharmacy or provider's storage guidance on how long a prepared solution remains usable.

Expecting oral and injectable results to match. Oral glutathione, including liposomal formats, has substantially lower bioavailability than injectable routes. Users who switch from an injectable protocol to oral and expect equivalent results routinely underestimate this gap. If oral is the preferred route, the timeline for visible effects is longer and real-world reports on efficacy are more variable.

Unsupervised high-frequency or high-dose use. Intensive skin brightening protocols that involve very high doses and high frequency are a distinct clinical category. Beyond a threshold that general wellness protocols do not approach, concerns include thyroid dysfunction, kidney function changes, and zinc depletion with extended use. Protocols in this intensity range belong in a clinical setting with qualified oversight.

Sourcing from unverifiable suppliers. Injectable glutathione must come from a licensed sterile compounding pharmacy. Products sourced from unverified suppliers carry unknown purity, sterility, and concentration, which undermines both safety and efficacy. There is no shortcut on this point.

Glutathione is not FDA-approved for human antioxidant use, detoxification, or skin lightening, and no universal clinical standard governs these protocols. Tested athletes should verify current WADA status before starting, as regulatory frameworks for injectable compounds vary by sport and jurisdiction.

Frequently Asked Questions

How long is a typical glutathione cycle?

Most injectable glutathione cycles run 8 to 12 weeks of active use, with skin brightening protocols often extending to the full 12 weeks before transitioning to maintenance. A two to four week off-cycle break typically follows the active phase. Your specific cycle length depends on your goal and delivery route.

How often do you take glutathione?

Injectable protocols are most commonly run two to three times per week during the active phase, which aligns with glutathione's approximately 72-hour half-life. Oral protocols are typically dosed daily to offset the lower bioavailability of the digestive route. After the primary goal is met, injectable maintenance drops to bi-weekly or monthly.

Does glutathione need a loading phase?

Glutathione uses an initiation phase rather than a traditional loading phase. The dose does not spike higher during initiation; it starts at the lower end of the active range for one to two weeks to assess tolerability, then steps into the full active protocol. The dose stays consistent across both phases.

Do you need to cycle off glutathione?

Yes, off-cycle breaks are standard in most injectable glutathione protocols. Cycling off allows the body to reassert its own endogenous glutathione production, which can be suppressed during extended exogenous supplementation. Most protocols include two to four weeks off after 8 to 12 weeks of active use.

Does the delivery route affect how fast glutathione works?

Yes, significantly. IV infusions offer the highest bioavailability and fastest onset, with some users reporting energy changes within days. Subcutaneous and intramuscular injections offer intermediate bioavailability, with effects typically emerging from weeks two to five. Oral glutathione has substantially lower bioavailability, and user-reported timelines are longer and more variable than for injectable routes.

Can glutathione be combined with other compounds?

Glutathione is commonly paired with Vitamin C, NAD+, and NAC in real-world protocols. Vitamin C is widely used for synergistic antioxidant support, though people with G6PD deficiency should avoid combining the two at high doses. NAC, a glutathione precursor, is frequently used during off-cycle periods to help sustain endogenous production. Confirm any combination with a qualified healthcare provider before starting.

Disclaimer

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world protocols for glutathione in one place.